Table Of Contents
1 Introduction 19
1.1 Objectives Of The Study 19
1.2 Market Definition 19
1.3 Overview Of Asia-Pacific Angioplasty Balloons Market 19
1.4 Currency And Pricing 20
1.5 Limitation 20
1.6 Markets Covered 21
2 Market Segmentation 23
2.1 Markets Covered 23
2.2 Geographic Scope 24
2.3 Years Considered For The Study 25
2.4 Currency And Pricing 25
2.5 Research Methodology 26
2.6 Primary Interviews With Key Opinion Leaders 29
2.7 Secondary Sources 30
2.8 Assumptions 30
3 Market Overview 31
3.1 Drivers 33
3.1.1 Growing Incidences Of Target Disease 33
3.1.2 New Product Innovations 34
3.1.3 Technological Advancement In Cardiovascular Disease Treatment 35
3.1.4 Rising Number Of Geriatric Population 36
3.2 Restraints 36
3.2.1 Increase In Number Of Market Players 36
3.2.2 Price Clash Due To Increase In The Number Of Market Players 37
3.3 Opportunities 38
3.3.1 Mergers And Acquisitions 38
3.3.2 Growing Number Of Angioplasty Procedure 38
3.4 Challenges 39
3.4.1 Lack Of Trained Staff 39
4 Executive Summary 40
5 Premium Insights 43
6 Asia-Pacific Angioplasty Balloons Market, By Type 46
6.1 Overview 47
6.2 Plain Old Balloon Angioplasty (Poba) 49
6.3 Drug-Coated Balloon (Dcb) Angioplasty 50
6.4 Cutting Balloons 51
6.5 Scoring Balloons 52
6.6 Stent Graft Balloon Catheter 53
7 Asia-Pacific Angioplasty Balloons Market, By Material 54
7.1 Overview 55
7.2 Nylon 57
7.3 Polyurethane 58
7.4 Silicone Urethane Co-Polymers 59
7.5 Other 60
8 Asia-Pacific Angioplasty Balloons Market, By Balloon Type 61
8.1 Overview 62
8.2 Semi-Compliant 64
8.3 Non-Compliant 65
9 Asia-Pacific Angioplasty Balloons Market, By Disease Indication 66
9.1 Overview 67
9.2 Coronary Angioplasty 69
9.3 Peripheral Angioplasty 70
9.4 Carotid Angioplasty 71
9.5 Renal Artery Angioplasty 72
9.6 Venous Angioplasty 73
10 Asia-Pacific Angioplasty Balloons Market, By End User 74
10.1 Overview 75
10.2 Ambulatory Surgical Centers 77
10.3 Hospitals 78
10.4 Specialty Clinics 79
10.5 Diagnostic Centers 80
10.6 Cath Lab 81
11 Asia-Pacific Angioplasty Balloons Market By Geography 82
11.1 Asia-Pacific 82
11.1.1 China 90
11.1.2 Japan 93
11.1.3 India 96
11.1.4 Australia 99
11.1.5 South Korea 102
11.1.6 Malaysia 105
11.1.7 Thailand 108
11.1.8 Singapore 111
11.1.9 Indonesia 114
11.1.10 Philippines 117
11.1.11 Rest Of Asia Pacific 120
12 Asia-Pacific Angioplasty Balloons Market, Company Landscape 121
12.1 Company Share Analysis; Asia-Pacific 121
13 Company Profiles 122
13.1 Medtronic 122
13.1.1 Company Overview 122
13.1.2 Revenue Analysis 122
13.1.3 Company Share Analysis (%) 123
13.1.4 Product Portfolio 123
13.1.5 Recent Developments 124
13.2 C. R. Bard, Inc. (Part Of Becton, Dickinson And Company) 125
13.2.1 Company Overview 125
13.2.2 Geographic Presence 125
13.2.3 Company Share Analysis (%) 126
13.2.4 Product Portfolio 126
13.2.5 Recent Developments 127
13.3 Boston Scientific Corporation 128
13.3.1 Company Overview 128
13.3.2 Revenue Analysis 128
13.3.3 Company Share Analysis (%) 129
13.3.4 Product Portfolio 129
13.3.5 Recent Developments 130
13.4 Abbott Laboratories 131
13.4.1 Company Overview 131
13.4.2 Revenue Analysis 131
13.4.3 Product Portfolio 132
13.4.4 Recent Developments 132
13.5 Angiodynamics, Inc. 133
13.5.1 Company Overview 133
13.5.2 Revenue Analysis 133
13.5.3 Product Portfolio 134
13.5.4 Recent Developments 134
13.6 B. Braun Melsungen Ag 135
13.6.1 Company Overview 135
13.6.2 Revenue Analysis 135
13.6.3 Product Portfolio 136
13.6.4 Recent Developments 136
13.7 Biomerics, Llc 137
13.7.1 Company Overview 137
13.7.2 Geographic Presence 137
13.7.3 Product Portfolio 138
13.7.4 Recent Developments 138
13.8 Biotronik Se & Co. Kg 139
13.8.1 Company Overview 139
13.8.2 Geographic Presence 139
13.8.3 Product Portfolio 140
13.8.4 Recent Developments 140
13.9 Cook Medical Incorporated 141
13.9.1 Company Overview 141
13.9.2 Geographic Presence 141
13.9.3 Product Portfolio 142
13.9.4 Recent Developments 142
13.10 Cordis Corporation 143
13.10.1 Company Overview 143
13.10.2 Geogrphic Presence 143
13.10.3 Product Portfolio 144
13.10.4 Recent Developments 145
13.11 Hexacath 146
13.11.1 Company Overview 146
13.11.2 Product Portfolio 146
13.11.3 Recent Developments 146
13.12 Jotec Ag 147
13.12.1 Company Overview 147
13.12.2 Revenue Analysis 147
13.12.3 Product Portfolio 148
13.12.4 Recent Developments 148
13.13 Koninklijke Philips N.V. 149
13.13.1 Company Overview 149
13.13.2 Revenue Analysis 149
13.13.3 Product Portfolio 150
13.13.4 Recent Developments 150
13.14 Microport Scientific 151
13.14.1 Company Overview 151
13.14.2 Revenue Analysis 151
13.14.3 Product Portfolio 152
13.14.4 Recent Developments 152
13.15 Nipro Medical Corporation 153
13.15.1 Company Overview 153
13.15.2 Revenue Analysis 153
13.15.3 Product Portfolio 154
13.15.4 Recent Developments 154
13.16 Palex Medical Sa 155
13.16.1 Company Overview 155
13.16.2 Geographic Presence 155
13.16.3 Product Portfolio 156
13.16.4 Recent Developments 156
13.17 Panmed Us 157
13.17.1 Company Overview 157
13.17.2 Product Portfolio 157
13.17.3 Recent Developments 158
13.18 Stryker 159
13.18.1 Company Overview 159
13.18.2 Revenue Analysis 159
13.18.3 Product Portfolio 160
13.18.4 Recent Developments 160
13.19 Teleflex Inororated 161
13.19.1 Company Overview 161
13.19.2 Revenue Analysis 161
13.19.3 Product Portfolio 162
13.19.4 Recent Developments 162
13.20 Terumo Corporation 163
13.20.1 Company Overview 163
13.20.2 Revenue Analysis 163
13.20.3 Product Portfolio 164
13.20.4 Recent Developments 165
14 Latest Reports 166
?